ConvaTec Group PLC
CTEC
Company Profile
Business description
Originally spun out of Bristol-Myers Squibb, ConvaTec designs, manufactures, and markets advanced wound care, ostomy, continence care, and infusion sets for the acute-care hospital and chronic-care home settings. Advanced wound care and ostomy supplies are the largest divisions, accounting for 33% and 28% of total revenue, respectively. Continence care has become a slightly smaller business (21% of revenue) following the decision to exit the acute care market, and infusion sets contribute 18% of consolidated revenue.
Contact
20 Eastbourne Terrace
7th Floor
Paddington
LondonW2 6LG
GBRT: +44 7826447807
Sector
Healthcare
Stock type
Defensive
Industry
Medical Instruments & Supplies
Fiscal Year End
31 December 2025
Employees
10,489
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,826.40 | 15.50 | -0.18% |
CAC 40 | 7,723.47 | 27.20 | 0.35% |
DAX 40 | 24,073.67 | 286.22 | 1.20% |
Dow JONES (US) | 44,218.74 | 609.79 | -1.36% |
FTSE 100 | 8,806.53 | 16.38 | -0.19% |
HKSE | 23,887.83 | 28.23 | -0.12% |
NASDAQ | 20,362.08 | 239.03 | -1.16% |
Nikkei 225 | 39,587.68 | 223.20 | -0.56% |
NZX 50 Index | 12,764.95 | 1.65 | -0.01% |
S&P 500 | 6,209.34 | 70.01 | -1.11% |
S&P/ASX 200 | 8,589.30 | 13.70 | -0.16% |
SSE Composite Index | 3,473.13 | 0.81 | 0.02% |